Tobacco Products
FDA’s Center for Tobacco Products (CTP) works to ensure a healthier life for every family.
Topic Paragraphs
Latest Updates from the Center for Tobacco Products
FDA Targets Illegal E-Cigarettes Emerging in Popularity Among Youth
Rapid surveillance and data-driven approach helped inform actions
Retailers Warned to Stop Selling Illegal Youth-Appealing E-Cigarettes
Retailers were given 15 working days to respond with corrective action or risk enforcement.
CTP Director Brian King Co-Authors New Commentary in Addiction Journal
Read “Opportunities and Considerations for Addressing Misperceptions About the Relative Risks of Tobacco Products Among Adult Smokers”
Tobacco Product Marketing Granted Orders (MGO)
To date, the FDA has authorized 23 tobacco-flavored e-cigarette products and devices. These are the only e-cigarette products that currently may be lawfully sold in the U.S. The distribution or sale of unlawfully marketed products is subject to enforcement action.
See the Legal E-Cigarette Products to Sell and Other MGOs
Actions to Address Recommendations from the Reagan-Udall Foundation Evaluation
At the request of FDA Commissioner Dr. Robert Califf, an independent expert panel facilitated by the Reagan-Udall Foundation (RUF) conducted an operational evaluation of CTP. A final report from the RUF evaluation included 15 recommendations, and in February 2023, CTP published a webpage with detailed plans to address each of the recommendations as quickly as possible. This webpage will be updated routinely to reflect CTP’s latest progress.
Learn About CTP’s Actions to Address the RUF Evaluation
Contact CTP
1-877-287-1373 (9am - 4pm ET)
For General Inquiries: AskCTP@fda.hhs.gov
Center for Tobacco Products
Food and Drug Administration
10903 New Hampshire Avenue
Document Control Center
Building 71, Room G335
Silver Spring, MD 20993-0002